BioSpace News Archive

BioMidwest

ZyVersa Therapeutics’ CEO, Stephen C. Glover to Appear on Benzinga ‘All Access’

ZyVersa Therapeutics, Inc. announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, will appear on Benzinga All Access on April 18, 2023.

April 12, 2023

·

4 min read

Pharm Country

Navrogen Presents Preclinical Data on NAV-001 Antibody-Drug Conjugate and NAV-003 Bispecific Programs at the 2023 American Association for Cancer Research Annual Meeting

Navrogen, Inc. will be presenting new preclinical data on its NAV-001 antibody-drug conjugate (ADC) and NAV-003 bispecific programs at the 2023 American Association for Cancer Research (AACR) Conference in Orlando, Florida on April 17 and 18.

April 12, 2023

·

2 min read

Pharm Country

Reaction Biology to Present Data at AACR 2023 Showcasing Expansive Capabilities in Immuno-Oncology Drug Discovery and Development

Reaction Biology (“Reaction” or the “Company”) today announced that eleven abstracts highlighting data from the Company’s expanding suite of research offerings will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, held April 14-19, 2023, in Orlando, Florida.

April 12, 2023

·

5 min read

Drug Development

Altamira Therapeutics Announces Publication of Positive Results from Phase 2 Trial with AM-125 in Acute Vestibular Syndrome in Leading Peer Reviewed Journal

Altamira Therapeutics (“Altamira” or the “Company”) (Nasdaq:CYTO) today announced the publication of the detailed results from its TRAVERS Phase 2 trial with AM-125 (intranasal betahistine) in surgery-induced acute vestibular syndrome (AVS).

April 12, 2023

·

8 min read

BioMidwest

CancerVAX CEO Ryan Davies Discusses Cancer Research with Leading Pediatric Hematologic Oncologist

CancerVAX, Inc. reported that CEO Ryan Davies spoke about the importance of cancer immunotherapy with Dr. Satiro De Oliveira, a principal investigator in the Company’s cancer research program at UCLA.

April 12, 2023

·

3 min read

Nerivio® Proven Effective in Real-World Setting as Drug-Free Acute Treatment of Migraine for Adolescents

Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, recently had the results of a real-world analysis of Nerivio® for acute treatment of migraine in adolescents published in the journal Pediatric Neurology.

April 12, 2023

·

5 min read

Policy

Awakn Life Sciences Increases Ownership of Awakn Bristol to 100% and Provides Corporate Update

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), is today providing a corporate update.

April 12, 2023

·

5 min read

Business

MaxCyte to Report First Quarter 2023 Financial Results on May 10, 2023

MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT) today announced that it will release financial results for the first quarter 2023 after the U.S. market close on Wednesday, May 10th, 2023.

April 12, 2023

·

2 min read

Pharm Country

Optinose to Present at the Needham Virtual Healthcare Conference - April 12, 2023

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 17, 2023 at 3:45 p.m. ET.

April 12, 2023

·

1 min read

Genetown

Immuneering to Present at the 22nd Annual Needham Virtual Healthcare Conference

Immuneering Corporation (Nasdaq: IMRX) today announced that management will present at the 22nd Annual Needham Virtual Healthcare Conference to discuss the company’s pipeline, platform, and business strategy.

April 12, 2023

·

1 min read